LOW RISK PROSTATE CANCER
Clinical trials for LOW RISK PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new LOW RISK PROSTATE CANCER trials appear
Sign up with your email to follow new studies for LOW RISK PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a short drug course keep prostate cancer at bay?
Disease control CompletedThis study tested if adding a 6-month course of the drug apalutamide to standard 'watchful waiting' (active surveillance) could help men with low-risk prostate cancer. Researchers wanted to see if the drug could slow the cancer's progression and delay the need for more invasive t…
Matched conditions: LOW RISK PROSTATE CANCER
Phase: PHASE2 • Sponsor: Institut Paoli-Calmettes • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Zapping prostate tumors with microwaves: new approach aims to spare side effects
Disease control CompletedThis study tested a new, targeted procedure using microwaves to destroy the main tumor in men with low-risk prostate cancer. The goal was to see if this approach was precise and safe enough to treat the cancer while causing fewer side effects like urinary and sexual problems comp…
Matched conditions: LOW RISK PROSTATE CANCER
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC